Skip to main content
SpringerLink
Log in

Basal Cell Carcinoma

  • Chapter
  • First Online:
Clinical Ophthalmic Oncology

  • 503 Accesses

Abstract

Basal cell carcinoma (BCC) is the most common cutaneous malignancy in the periocular area. While the mortality from BCC is low, it is capable of extensive tissue destruction, and the morbidity may be considerable. The main risk factor is ultraviolet irradiation. The most important diagnostic evaluation is histopathologic examination of the excised tissue. The main treatment modality for BCC is surgical excision of the lesion with microscopic monitoring of its margins or Mohs’ microsurgery. Long-term clinical follow-up after treatment is necessary.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Margo CE, Waltz K. Basal cell carcinoma of the eyelid and periocular skin. Surv Ophthalmol. 1993;38:169–92.

    Article  CAS  Google Scholar 

  2. Yin VT, Merritt HA, Sniegowski M, et al. Eyelid and ocular surface carcinoma: diagnosis and management. Clin Dermatol. 2015;33:159–69.

    Article  CAS  Google Scholar 

  3. Allali J, D’Hermies F, Renard G. Basal cell carcinomas of the eyelids. Ophthalmologica. 2005;219:57–71.

    Article  CAS  Google Scholar 

  4. Malhotra R, Huilgol SC, Huynh NT, et al. The Australian Mohs Database, Part I: periocular basal cell carcinoma. Experience over 7 years. Ophthalmology. 2004;111:624–30.

    Article  Google Scholar 

  5. Paavilainen V, Tuominen J, Pukkala E, et al. Basal cell carcinoma of the eyelid in Finland during 1953–97. Acta Ophthalmol Scand. 2005;83:215–20.

    Article  Google Scholar 

  6. Lim VSY, Amrith S. Declining incidence of eyelid cancers in Singapore over 13 years: population-based data from 1996 to 2008. Br J Ophthalmol. 2012;96:1462–5.

    Article  Google Scholar 

  7. Shi Y, Jia R, Fan X. Ocular basal cell carcinoma: a brief literature review of clinical diagnosis and treatment. Onco Targets Ther. 2017;10:2483–9. https://doi.org/10.2147/OTT.S130371.. eCollection 2017. Review.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Wade TR, Ackerman AB. The many faces of basal-cell carcinoma. J Dermatol Surg Oncol. 1978;4:23–8.

    Article  CAS  Google Scholar 

  9. Bakis S, Irwig L, Wood G, et al. Exfoliative cytology as a diagnostic test for basal cell carcinoma: a meta-analysis. Br J Dermatol. 2004;150:829–36.

    Article  CAS  Google Scholar 

  10. Leibovitch I, McNab A, Sulivan T, et al. Orbital invasion by periocular basal cell carcinoma. Ophthalmology. 2005;112:717–23.

    Article  Google Scholar 

  11. Allan E, Pye DA, Levine EL, et al. Non-invasive pulsed ultrasound quantification of the resolution of basal cell carcinomas after photodynamic therapy. Lasers Med Sci. 2002;17:230–7.

    Article  CAS  Google Scholar 

  12. Nori S, Rius-Diaz F, Cuevas J, et al. Sensitivity and specificity of reflectance-mode confocal microscopy for in vivo diagnosis of basal cell carcinoma: a multicenter study. J Am Acad Dermatol. 2004;51:923–30.

    Article  Google Scholar 

  13. Murra DE, Torres A, Schanbacher CF, et al. Detection of residual basal cell carcinoma by in vivo confocal microscopy. Dermatol Surg. 2005;31:538–41.

    Article  Google Scholar 

  14. Cook BE Jr, Bartley GB. Treatment options and future prospects for the management of eyelid malignancies: an evidence-based update. Ophthalmology. 2001;108:2088–98.

    Article  Google Scholar 

  15. Malhotra R, Huilgol SC, Huynh NT, et al. The Australian Mohs Database, Part II. Periocular basal cell carcinoma outcome at 5-year follow-up. Ophthalmology. 2004;111:631–6.

    Article  Google Scholar 

  16. Morris DS, Elzaridi E, Clarke L, et al. Periocular basal cell carcinoma: 5-year outcome following slow Mohs surgery with formalin-fixed paraffin-embedded sections and delayed closure. Br J Ophthalmol. 2009;93(4):474–6.

    Article  CAS  Google Scholar 

  17. Lindgren G, Larko O. Long-term follow-up of cryosurgery of basal cell carcinoma of the eyelid. J Am Acad Dermatol. 1997;36:742–6.

    Article  CAS  Google Scholar 

  18. Tuppurainen K. Cryotherapy for eyelid and periocular basal cell carcinomas: outcome in 166 cases over an 8-year period. Graefes Arch Clin Exp Ophthalmol. 1995;233:205–8.

    Article  CAS  Google Scholar 

  19. Kokoszka A, Scheinfeld N. Evidence-based review of the use of cryosurgery in treatment of basal cell carcinoma. Dermatol Surg. 2003;29:566–71.

    PubMed  Google Scholar 

  20. Jaramillo-Averbe F. Cryosurgery in difficult to treat basal cell carcinoma. Int J Dermatol. 2000;39:223–9.

    Article  Google Scholar 

  21. Lindgren G, Larko O. Cryosurgery of eyelid basal cell carcinomas including 782 cases treated over 30 years. Acta Ophthalmol. 2014;92:787–92.

    Article  Google Scholar 

  22. Avril MF, Auperin A, Margulis A, et al. Basal cell carcinoma of the face: surgery or radiotherapy? Results of a randomized study. Br J Cancer. 1997;76:100–6.

    Article  CAS  Google Scholar 

  23. Jefford M, Kiffer JD, Somers G, et al. Metastatic cell carcinoma: rapid symptomatic response to cisplatin and paclitaxel. ANZ J Surg. 2004;74:704–5.

    Article  Google Scholar 

  24. Wang I, Bauer B, Andersson-Engels S, et al. Photodynamic therapy utilising topical delta-aminolevulinic acid in non-melanoma skin malignancies of the eyelid and the periocular skin. Acta Ophthalmol Scand. 1999;77:182–8.

    Article  CAS  Google Scholar 

  25. Ingves C, Jemec GBE. Combined imiquimod and acitretin for non-surgical treatment of basal cell carcinoma. Scand J Plast Reconstr Surg Hand Surg. 2003;37:293–5.

    Article  Google Scholar 

  26. Rhodes LE, de Rie M, Enström Y, et al. Photodynamic therapy using topical methyl aminolevulinate vs surgery for nodular basal cell carcinoma. Results of a multicenter randomized prospective trial. Arch Dermatol. 2004;140:17–23.

    CAS  PubMed  Google Scholar 

  27. Garcia-Martin E, Gil-Arribas LM, Idoipe M, et al. Comparison of imiquimod 5% cream versus radiotherapy as treatment for eyelid basal cell carcinoma. Br J Ophthalmol. 2011;95:1393–6.

    Article  CAS  Google Scholar 

  28. Sekulic A, Migden M, Oro A, et al. Efficacy and safety of vismodegib in advanced basal-cell carcinoma. N Engl J Med. 2012;366:2171–9.

    Article  CAS  Google Scholar 

  29. Curson C, Weedon D. Spontaneous regression in basal cell carcinoma. J Cutan Pathol. 1979;6:432–7.

    Article  CAS  Google Scholar 

  30. Edge SE, Byrd DR, Carducci MA, et al., editors. Carcinoma of the eyelid. In: AJCC cancer staging manual. 7th ed. New York: Springer; 2010.

    Google Scholar 

  31. Crawford C, Fernelius C, Young P, et al. Application of the AJCC 7th edition carcinoma of the eyelid staging system: a medical center pathology based, 15-year review. Clin Ophthalmol. 2011;5:1645–8.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Ophthalmology, Eye Histopathology Laboratory, Goldschleger Eye Institute, Sheba Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

    Mordechai Rosner

  2. Department of Ophthalmology, Ocular Oncology Center, Goldschleger Eye Institute, Sheba Medical Center, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel

    Ido Didi Fabian

Authors
  1. Mordechai Rosner
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ido Didi Fabian
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Ocular Onocology Service and Ophthalmic Pathology Laboratory, Department of Ophthalmology, Hadassah - Hebrew University Medical Center, Jerusalem, Israel

    Jacob Pe'er

  2. Department of Ophthalmic Oncology, Cole Eye Institute, Cleveland Clinic, Cleveland, OH, USA

    Arun D. Singh

  3. Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK

    Bertil E. Damato

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Rosner, M., Fabian, I.D. (2019). Basal Cell Carcinoma. In: Pe'er, J., Singh, A., Damato, B. (eds) Clinical Ophthalmic Oncology. Springer, Cham. https://doi.org/10.1007/978-3-030-06046-6_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-06046-6_4

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-06045-9

  • Online ISBN: 978-3-030-06046-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation